David BA - Theralase Technologies Pres Division
| TLTFF Stock | USD 0.12 0.01 9.09% |
Insider
David BA is Pres Division of Theralase Technologies
| Phone | 416 699 5273 |
| Web | https://www.theralase.com |
Theralase Technologies Management Efficiency
The company has return on total asset (ROA) of (0.5866) % which means that it has lost $0.5866 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.131) %, meaning that it generated substantial loss on money invested by shareholders. Theralase Technologies' management efficiency ratios could be used to measure how well Theralase Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Kuznar | Via Renewables | N/A | |
| , PharmD | Certara | N/A | |
| Helen Hrdy | National Research Corp | 58 | |
| Jona Raasch | National Research Corp | 65 | |
| Paul Konikowski | Via Renewables | 51 | |
| William Feehery | Certara | 53 | |
| CPA CPA | National Research Corp | 66 | |
| Mike Barajas | Via Renewables | 39 | |
| Andrew Schemick | Certara | 50 | |
| Nicolette Sherman | Certara | 54 | |
| Jaap Mandema | Certara | N/A | |
| Barbara Clay | Via Renewables | 52 | |
| Gregory MS | National Research Corp | N/A | |
| William III | Via Renewables | 58 | |
| Stephen Rabalais | Via Renewables | N/A | |
| Jon Boumstein | National Research Corp | N/A | |
Management Performance
| Return On Equity | -1.13 | |||
| Return On Asset | -0.59 |
Theralase Technologies Leadership Team
Elected by the shareholders, the Theralase Technologies' board of directors comprises two types of representatives: Theralase Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theralase. The board's role is to monitor Theralase Technologies' management team and ensure that shareholders' interests are well served. Theralase Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theralase Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lori Leach, Marketing Consultant | ||
| Terry DVM, Equine Consultant | ||
| Roger DumoulinWhite, President CEO, Director | ||
| David BA, Pres Division | ||
| DSc MD, Chief CEO | ||
| Vaughn Wyant, Marketing Consultant | ||
| Kristina CPA, CFO Director |
Theralase Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Theralase Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.13 | |||
| Return On Asset | -0.59 | |||
| Operating Margin | (5.50) % | |||
| Current Valuation | 51.77 M | |||
| Shares Outstanding | 216.5 M | |||
| Shares Owned By Insiders | 2.56 % | |||
| Price To Earning | (9.16) X | |||
| Price To Book | 20.01 X | |||
| Price To Sales | 52.92 X | |||
| Revenue | 780.64 K |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theralase Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Theralase Technologies information on this page should be used as a complementary analysis to other Theralase Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Theralase OTC Stock analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |